In addition to developing innovative methods of performing complex coronary revascularization, repairing thoracic aortic aneurysms, and repairing and/or replacing damaged heart valves, faculty of the Division of Cardiothoracic Surgery of the Emory University School of Medicine are international experts and teachers of such minimally invasive procedures as off-pump coronary artery bypass and endoscopic atraumatic coronary artery bypass.

Our surgeons are also at the forefront of the use of such technologies as ventricular assist devices—as either a bridge to transplant or as destination therapy—and robotically assisted, minimally invasive coronary artery bypass surgery.

The Division's current research efforts include include evaluation of new surgical methods, technologies, devices, and innovative pharmaceutical and bioengineered products related to cardiothoracic surgery; protection of the heart and circulation during cardiac surgical procedures; the efficacy of nitric oxide and hydrogen sulfide as cytoprotective agents; refinement of surgical and transcatheter heart valve therapies; and development of polymeric materials to control local cardiac mechanics.

The ACGME-approved cardiothoracic residency is a three year program featuring elective rotations in the first and third year. This structure provides residents with the opportunity to focus on subspecialties in cardiothoracic surgery.